Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 27 entries
View as:

PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400

Phase: N/A Priority: Normal
NCT ID: NCT00599404 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00995410 Org: User:
Start: 10/31/09 End: 05/31/11 Due: 05/31/12

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

Phase: N/A Priority: Normal
NCT ID: NCT00527787 Org: User:
Start: 09/30/07 End: 10/31/08 Due: 10/31/09

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

Phase: N/A Priority: Normal
NCT ID: NCT00293657 Org: User:
Start: 12/31/05 End: 04/30/06 Due: 04/30/07

Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00665431 Org: User:
Start: 04/30/08 End: 01/31/09 Due: 01/31/10

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00961350 Org: User:
Start: 10/31/09 End: 02/29/12 Due: 02/28/13

To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT00442052 Org: User:
Start: 11/30/06 End: 01/31/07 Due: 01/31/08

To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches

Phase: N/A Priority: Normal
NCT ID: NCT00433732 Org: User:
Start: 08/31/04 End: 04/30/05 Due: 04/30/06

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec

Phase: N/A Priority: Normal
NCT ID: NCT00594854 Org: User:
Start: 09/30/07 End: 09/30/08 Due: 09/30/09

A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

Phase: N/A Priority: Normal
NCT ID: NCT00527904 Org: User:
Start: 03/31/07 End: 03/31/09 Due: 03/31/10

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

Phase: N/A Priority: Normal
NCT ID: NCT01129011 Org: User:
Start: 09/30/07 End: 10/31/08 Due: 10/31/09

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

Phase: N/A Priority: Normal
NCT ID: NCT00367211 Org: User:
Start: 09/30/06 End: 09/30/07 Due: 09/30/08

Study Evaluating the Effect of Food on the Bioavailability of PN400 Components

Phase: N/A Priority: Normal
NCT ID: NCT00676442 Org: User:
Start: 05/31/08 End: 06/30/08 Due: 06/30/09

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00960869 Org: User:
Start: 10/31/09 End: 02/29/12 Due: 02/28/13

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

Phase: N/A Priority: Normal
NCT ID: NCT00700687 Org: User:
Start: 06/30/08 End: 07/31/08 Due: 07/31/09

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00692055 Org: User:
Start: 06/30/08 End: 07/31/08 Due: 07/31/09

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

Phase: N/A Priority: Normal
NCT ID: NCT01557335 Org: User:
Start: 11/30/10 End: 02/28/11 Due: 02/28/12

A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT00441519 Org: User:
Start: 02/28/07 End: 04/30/07 Due: 04/30/08

A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels

Phase: N/A Priority: Normal
NCT ID: NCT00749385 Org: User:
Start: 08/31/08 End: 10/31/08 Due: 10/31/09

Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00632086 Org: User:
Start: 02/29/08 End: 02/29/08 Due: 02/28/09

An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00442208 Org: User:
Start: 01/31/07 End: 02/29/08 Due: 02/28/09

Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00665743 Org: User:
Start: 03/31/08 End: 06/30/08 Due: 06/30/09

The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

Phase: N/A Priority: Normal
NCT ID: NCT00442221 Org: User:
Start: 05/31/04 End: 08/31/04 Due: 08/31/05

Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib

Phase: N/A Priority: Normal
NCT ID: NCT00729495 Org: User:
Start: 07/31/08 End: 10/31/08 Due: 10/31/09

Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy

Phase: N/A Priority: Normal
NCT ID: NCT00293631 Org: User:
Start: 11/30/05 End: 03/31/06 Due: 03/31/07